Cargando…
Genetic inhibition of RIPK3 ameliorates functional outcome in controlled cortical impact independent of necroptosis
Traumatic brain injury (TBI) is a leading cause of death and disability with no specific effective therapy, in part because disease driving mechanisms remain to be elucidated. Receptor interacting protein kinases (RIPKs) are serine/threonine kinases that assemble multi-molecular complexes that induc...
Autores principales: | Wu, Limin, Chung, Joon Yong, Cao, Tian, Jin, Gina, Edmiston, William J., Hickman, Suzanne, Levy, Emily S., Whalen, Jordyn A., Abrams, Eliza Sophie LaRovere, Degterev, Alexei, Lo, Eng H., Tozzi, Lorenzo, Kaplan, David L., El Khoury, Joseph, Whalen, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578385/ https://www.ncbi.nlm.nih.gov/pubmed/34753914 http://dx.doi.org/10.1038/s41419-021-04333-z |
Ejemplares similares
-
Targeting RIPK1 for the treatment of human diseases
por: Degterev, Alexei, et al.
Publicado: (2019) -
Targeting RIPK1,2,3 to combat inflammation
por: Bullock, Alex N., et al.
Publicado: (2015) -
Necroptosis: Fifty shades of RIPKs
por: Ichim, Gabriel, et al.
Publicado: (2014) -
Localization of Multi-Lamellar Vesicle Nanoparticles to Injured Brain Tissue in a Controlled Cortical Impact Injury Model of Traumatic Brain Injury in Rodents
por: Whitener, Ricky, et al.
Publicado: (2022) -
Discovery of a Potent RIPK3 Inhibitor for the Amelioration of Necroptosis-Associated Inflammatory Injury
por: Xia, Kaijiang, et al.
Publicado: (2020)